ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NMPA accepts NDA for biosimilar product candidate of Rituximab biospectrumasia
June 28, 2019IBI301 is a recombinant human-mouse chimeric anti-cell surface protein (anti-CD20) monoclonal antibody for injection co-developed by Lilly and Innovent for the treatment of non-Hodgkin's lymphoma (NHL) and other diseases.
Pharma Sources Insight January 2025
